-       Report 
   - October 2025
    -  184 Pages 
    Global
   
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                -       Report 
   - November 2025
    -  189 Pages 
    Global
   
   From       €5258EUR$5,850USD£4,611GBP 
                -       Report 
   - June 2025
    -  140 Pages 
    Global
   
   From       €4490EUR$4,995USD£3,937GBP 
                  -       Report 
   - August 2025
    -  186 Pages 
    Global
   
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                  -       Report 
   - April 2025
    -  150 Pages 
    Global
   
   From       €2291EUR$2,549USD£2,009GBP 
      €2696EUR$2,999USD£2,364GBP 
                 -       Report 
   - January 2025
    -  100 Pages 
    Global
   
   From       €5348EUR$5,950USD£4,690GBP 
                -       Report 
   - April 2025
    -  190 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                  -       Report 
   - October 2025
    -  195 Pages 
    Global
   
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                -       Report 
   - March 2025
    -  200 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - February 2025
    -  200 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - November 2025
    -  183 Pages 
    Global
   
   From       €5258EUR$5,850USD£4,611GBP 
                -       Report 
   - November 2025
    -  282 Pages 
    Global
   
   From       €5258EUR$5,850USD£4,611GBP 
                -       Report 
   - February 2025
    -  200 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                  -       Report 
   - May 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
                -       Report 
   - November 2024
     Global
   
   From       €6741EUR$7,500USD£5,912GBP 
                -       Report 
   - March 2025
    -  55 Pages 
    North America
   
   From       €5388EUR$5,995USD£4,726GBP 
                -       Report 
   - March 2025
    -  66 Pages 
    Europe
   
   From       €5388EUR$5,995USD£4,726GBP 
                -       Report 
   - March 2025
    -  66 Pages 
    Asia Pacific
   
   From       €5388EUR$5,995USD£4,726GBP 
                -       Report 
   - March 2025
    -  31 Pages 
    United States
   
   From       €4490EUR$4,995USD£3,937GBP 
                -       Report 
   - May 2023
    -  282 Pages 
    Global
   
   From       €4179EUR$4,650USD£3,665GBP 
             
         The Gamma Knife is a type of surgical device used to treat brain tumors and other neurological conditions. It is a non-invasive, radiation-based treatment that uses gamma rays to target and destroy cancerous cells. The Gamma Knife is a highly precise and effective treatment option, and is often used when traditional surgery is not an option. It is also used to treat conditions such as arteriovenous malformations, trigeminal neuralgia, and acoustic neuromas.
The Gamma Knife market is a rapidly    growing segment of the surgical device industry. It is a highly specialized market, with a focus on providing the most advanced and effective treatments for neurological conditions. The market is driven by the increasing demand for non-invasive treatments, as well as the need for more precise and targeted treatments.
Some of the major companies in the Gamma Knife market include Elekta, Accuray, Brainlab, and Varian Medical Systems. These companies are leading the way in developing and providing the most advanced and effective treatments for neurological conditions. Show Less   Read more